[1]Barchiesi F, Cogliati M, Esposto MC, et al. Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis.J Infect,2005,51(1):10-16.[2]Chang WC, Tzao C, Hsu HH, et al.Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients.Chest,2006,129(2):333-340.[3]刘又宁,佘丹阳,孙铁英,等.中国1998年至2007年临床确诊的肺真菌病患者的多中心回顾性调查.中华结核和呼吸杂志,2011,34(2):86-90.[4]颜召文,吴平平,蔡军, 等.急性肺隐球菌病合并肺出血尸检一例报道.上海交通大学学报(医学版),2007,27(8):1039-1040.[5]赖国祥,张玉华,林庆安,等.国内22年肺隐球菌病回顾性分析.中国实用内科杂志,2005,25(2):176-178.[6]Kishi K, Homma S, Kurosaki A, et al.A clinicopathological study of pulmonary cryptococcosis-chest CT and pathologic correlation.Nihon Kokyuki Gakkai Zasshi(Article in Japanese),2000,38(9):670-675.[7]徐作军.肺隐球菌感染的诊断和治疗.中华结核和呼吸杂志,2006,29(5):295-296.[8]Nadrous HF, Antonios VS, Terrell CL, et al.Pulmonary cryptococcosis in nonimmunocompromised patients.Chest,2003,124(6):2143-2147.[9]赵蓓蕾,施毅,桑红.现代肺部真菌病学.北京:人民军医出版社,2004:27-32.[10]钟小宁.原发性肺部隐球菌肺炎临床诊治.中国实用内科杂志,2003,23(6):333-334.[11]Saag MS, Graybill RJ, Larsen RA, et al.Practice guidelines for the management of cryptococcal disease.Infectious Diseases Society of America.Clin Infect Dis,2000,30(4):710-718.[12]Jarvis JN,Harrison TS.Pulmonary cryptococcosis(Review).Semin Respir Crit Care Med,2008,29(2):141-150. [13]Aberg JA.Pulmonary cryptococcosis in normal hosts:treat or observe.Chest,2003,124(6):2049-2051. [14]Núnez M, Peacock JE Jr, Chin R Jr. Pulmonary cryptococcosis in the immunocompetent host. Therapy with oral fluconazole: a report of four cases and a review of the literature.Chest,2000,118(2):527-534. |